C. S. Fuchs Et Al. , "Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.," JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018
Fuchs, C. S. Et Al. 2018. Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15 .
Fuchs, C. S., Ozguroglu, M., Bang, Y., Di Bartolomeo, M., Mandala, M., Ryu, M., ... Fornaro, L.(2018). Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.
Fuchs, Charles Et Al. "Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.," JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018
Fuchs, Charles S. Et Al. "Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018
Fuchs, C. S. Et Al. (2018) . "Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.
@article{article, author={Charles S. Fuchs Et Al. }, title={Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2018}